Increased use of generic drugs helps to save Medicare Part D billions

Share this article:
The Medicare Part D prescription drug program saved more than $33 billion in 2007 due to the use of generic drugs, according to a new government report. 

The Congressional Budget Office report also shows that another $14 billion per year in savings to the seniors' drug program can be expected as new generic drugs become available through 2012, The Associated Press reported. Trade lobbying group Pharmaceutical Care Management Association, which represents the interests of pharmacy benefits managers, was quick to trumpet the report's findings.

“Policymakers can increase savings for seniors and Medicare by leveraging additional generic opportunities and rejecting special protections in Part D that insulate drugmakers from competition by requiring drug plans cover ‘all or substantially all' drugs in at least six different drug classes, despite no evidence that patients have had difficulty accessing these drugs,” PCMA president and CEO Mark Merritt said in a statement released Wednesday.

Share this article:

More in News

Also in the news for August 22, 2014

Iowa's nursing homes lost, on average, 41% of their employees each year from 2010-2012 ... Researchers identify proteins necessary in wound healing ... More than 40% percent of SSDI recipients take opioid pain relievers, study says.

CMS: Many skilled nursing providers have poor Medicare certification and recertification practices

CMS: Many skilled nursing providers have poor Medicare ...

The rate of improper Medicare payments to skilled nursing facilities has increased largely due to issues with certification and recertification statements, according to a recently released government memorandum. The Centers ...

NY nursing home agrees to $2.2 million settlement in case of false documentation

NY nursing home agrees to $2.2 million settlement ...

Nursing home operator Ralex Services Inc. has agreed to a $2.2 million settlement in a whistleblower case involving forged documents at a facility in New Rochelle, New York.